These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 2704128

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Benefit-risk analysis for mass screening of stomach cancer in Japan. II. Genentic risk and cost of mass screening (author's transl)].
    Iinuma TA, Tateno Y, Umegaki Y, Hashizume T, Kitabatake T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Jul 25; 38(7):625-32. PubMed ID: 704295
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.
    de Vries AC, Kuipers EJ.
    Helicobacter; 2007 Nov 25; 12 Suppl 2():22-31. PubMed ID: 17991173
    [Abstract] [Full Text] [Related]

  • 27. The impact of mass screening on gastric cancer mortality in Japan.
    Kawai K, Watanabe Y.
    Gastrointest Endosc; 1998 Mar 25; 47(3):320-3. PubMed ID: 9540897
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The gastrochamber as a method of mass endoscopic examination].
    Poddubnyĭ BK, Pogorazdov VV.
    Sov Med; 1986 Mar 25; (2):57-9. PubMed ID: 3704763
    [No Abstract] [Full Text] [Related]

  • 31. [Programmed screening of the adult population in cancer detection].
    Denisov LE, Volodin VD.
    Vopr Onkol; 1984 Mar 25; 30(3):55-60. PubMed ID: 6710950
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [An experimental study on the physical examination system for psychic in-patients. 2nd report: a trial screening for stomach and uterine cancer].
    Hosomi J, Baba F, Matsuura Y.
    Seishin Shinkeigaku Zasshi; 1996 Mar 25; 98(1):1-10. PubMed ID: 8721095
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Characteristics and progress of treatment for gastric cancers detected by mass screening].
    Muta Y, Baba Y, Nishiyama M, Bandou K, Ogata S, Sakaguti K.
    Gan To Kagaku Ryoho; 1998 Aug 25; 25(10):1505-13. PubMed ID: 9725041
    [Abstract] [Full Text] [Related]

  • 37. [Role of modern fluorography in detecting cancer of the stomach during the conduct of mass screening of the population].
    Portnoĭ LM, Turovskiĭ BM, Kaluzhskiĭ AA, Vasil'ev IuD, Khasidashvili ISh.
    Vestn Rentgenol Radiol; 1986 Aug 25; (1):65-9. PubMed ID: 3705457
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Index screening in precancerous conditions and cancer of the stomach].
    Ismaĭlov AKh.
    Khirurgiia (Mosk); 1982 May 25; (5):46-8. PubMed ID: 7115495
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.